BelloNA, MillerE, ClearyK, WapnerR, ShimboD, TitaAT: Out of office blood pressure measurement in pregnancy and the postpartum period. Curr Hypertens Rep20: 101, 2018PubMed
BelloNA, MillerE, ClearyK, WapnerR, ShimboD, TitaAT: Out of office blood pressure measurement in pregnancy and the postpartum period. Curr Hypertens Rep 20: 101, 2018PubMed)| false
ScottG, GillonTE, PelsA, von DadelszenP, MageeLA: Guidelines-similarities and dissimilarities: A systematic review of international clinical practice guidelines for pregnancy hypertension. Am J Obstet Gynecol226: S1222–S1236, 202210.1016/j.ajog.2020.08.018PubMed
ScottG, GillonTE, PelsA, von DadelszenP, MageeLA: Guidelines-similarities and dissimilarities: A systematic review of international clinical practice guidelines for pregnancy hypertension. Am J Obstet Gynecol 226: S1222–S1236, 202210.1016/j.ajog.2020.08.018PubMed)| false
ReddyM, RolnikDL, HarrisK, LiW, MolBW, Da Silva CostaF, et al.: Challenging the definition of hypertension in pregnancy: A retrospective cohort study. Am J Obstet Gynecol222: 606.e1–606.e21, 2020
ReddyM, RolnikDL, HarrisK, LiW, MolBW, Da Silva CostaF, : Challenging the definition of hypertension in pregnancy: A retrospective cohort study. Am J Obstet Gynecol 222: 606.e1–606.e21, 2020)| false
BoneJN, MageeLA, SingerJ, NathanH, QureshiRN, SacoorC, et al.; CLIP study group: Blood pressure thresholds in pregnancy for identifying maternal and infant risk: A secondary analysis of Community-Level Interventions for Pre-eclampsia (CLIP) trial data. Lancet Glob Health9: e1119–e1128, 2021PubMed
BoneJN, MageeLA, SingerJ, NathanH, QureshiRN, SacoorC, ; CLIP study group: Blood pressure thresholds in pregnancy for identifying maternal and infant risk: A secondary analysis of Community-Level Interventions for Pre-eclampsia (CLIP) trial data. Lancet Glob Health 9: e1119–e1128, 2021PubMed)| false
TuckerKL, HodgkinsonJ, WilsonHM, CrawfordC, StevensR, Lay-FlurrieS, et al.: Current prevalence of self-monitoring of blood pressure during pregnancy: The BUMP Survey. J Hypertens39: 994–1001, 2021PubMed
TuckerKL, HodgkinsonJ, WilsonHM, CrawfordC, StevensR, Lay-FlurrieS, : Current prevalence of self-monitoring of blood pressure during pregnancy: The BUMP Survey. J Hypertens 39: 994–1001, 2021PubMed)| false
TuckerKL, BankheadC, HodgkinsonJ, RobertsN, StevensR, HeneghanC, et al.: How do home and clinic blood pressure readings compare in pregnancy?Hypertension72: 686–694, 2018PubMed
TuckerKL, BankheadC, HodgkinsonJ, RobertsN, StevensR, HeneghanC, : How do home and clinic blood pressure readings compare in pregnancy? Hypertension 72: 686–694, 2018PubMed)| false
ChappellLC, TuckerKL, GalalU, YuLM, CampbellH, Rivero-AriasO, et al.; BUMP 2 Investigators: Effect of self-monitoring of blood pressure on blood pressure control in pregnant individuals with chronic or gestational hypertension: The BUMP 2 Randomized Clinical Trial. JAMA327: 1666–1678, 2022PubMed
ChappellLC, TuckerKL, GalalU, YuLM, CampbellH, Rivero-AriasO, ; BUMP 2 Investigators: Effect of self-monitoring of blood pressure on blood pressure control in pregnant individuals with chronic or gestational hypertension: The BUMP 2 Randomized Clinical Trial. JAMA 327: 1666–1678, 2022PubMed)| false
MageeLA, BrownMA, HallDR, GupteS, HennessyA, KarumanchiSA, et al.: The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens27: 148–169, 2022PubMed
MageeLA, BrownMA, HallDR, GupteS, HennessyA, KarumanchiSA, : The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens 27: 148–169, 2022PubMed)| false
MageeLA, SharmaS, SeveneE, QureshiRN, MallapurA, MacuácuaSE, et al.; The Community-Level Interventions for Pre-eclampsia Study Group: Population-level data on antenatal screening for proteinuria; India, Mozambique, Nigeria, Pakistan. Bull World Health Organ98: 661–670, 2020PubMed
MageeLA, SharmaS, SeveneE, QureshiRN, MallapurA, MacuácuaSE, ; The Community-Level Interventions for Pre-eclampsia Study Group: Population-level data on antenatal screening for proteinuria; India, Mozambique, Nigeria, Pakistan. Bull World Health Organ 98: 661–670, 2020PubMed)| false
WaughJ, HooperR, LambE, RobsonS, ShennanA, MilneF, et al.: Spot protein-creatinine ratio and spot albumin-creatinine ratio in the assessment of pre-eclampsia: A diagnostic accuracy study with decision-analytic model-based economic evaluation and acceptability analysis. Health Technol Assess21: 1–90, 2017PubMed
WaughJ, HooperR, LambE, RobsonS, ShennanA, MilneF, : Spot protein-creatinine ratio and spot albumin-creatinine ratio in the assessment of pre-eclampsia: A diagnostic accuracy study with decision-analytic model-based economic evaluation and acceptability analysis. Health Technol Assess 21: 1–90, 2017PubMed)| false
von DadelszenP, PayneB, LiJ, AnserminoJM, Broughton PipkinF, CôtéAM, et al.; PIERS Study Group: Prediction of adverse maternal outcomes in pre-eclampsia: Development and validation of the fullPIERS model. Lancet377: 219–227, 2011PubMed
von DadelszenP, PayneB, LiJ, AnserminoJM, Broughton PipkinF, CôtéAM, ; PIERS Study Group: Prediction of adverse maternal outcomes in pre-eclampsia: Development and validation of the fullPIERS model. Lancet 377: 219–227, 2011PubMed)| false
JohnsonS, GordijnS, DamhuisS, GanzevoortW, BrownM, von DadelszenP, et al.; ISSHP: Diagnosis and monitoring of white coat hypertension in pregnancy: An ISSHP Consensus Delphi Procedure. Hypertension79: 993–1005, 2022PubMed
JohnsonS, GordijnS, DamhuisS, GanzevoortW, BrownM, von DadelszenP, ; ISSHP: Diagnosis and monitoring of white coat hypertension in pregnancy: An ISSHP Consensus Delphi Procedure. Hypertension 79: 993–1005, 2022PubMed)| false
RanaS, PoweCE, SalahuddinS, VerlohrenS, PerschelFH, LevineRJ, et al.: Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation125: 911–919, 2012PubMed
RanaS, PoweCE, SalahuddinS, VerlohrenS, PerschelFH, LevineRJ, : Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 125: 911–919, 2012PubMed)| false
ChappellLC, DuckworthS, SeedPT, GriffinM, MyersJ, MackillopL, et al.: Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: A prospective multicenter study. Circulation128: 2121–2131, 2013PubMed
ZeislerH, LlurbaE, ChantraineF, VatishM, StaffAC, SennströmM, et al.: Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med374: 13–22, 2016PubMed
ZeislerH, LlurbaE, ChantraineF, VatishM, StaffAC, SennströmM, : Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med 374: 13–22, 2016PubMed)| false
BianX, BiswasA, HuangX, LeeKJ, LiTK, MasuyamaH, et al.: Short-term prediction of adverse outcomes using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) ratio in Asian women with suspected preeclampsia. Hypertension74: 164–172, 2019PubMed
BianX, BiswasA, HuangX, LeeKJ, LiTK, MasuyamaH, : Short-term prediction of adverse outcomes using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) ratio in Asian women with suspected preeclampsia. Hypertension 74: 164–172, 2019PubMed)| false
GarovicVD, WhiteWM, VaughanL, SaikiM, ParashuramS, Garcia-ValenciaO, et al.: Incidence and long-term outcomes of hypertensive disorders of pregnancy. J Am Coll Cardiol75: 2323–2334, 2020PubMed
HomerCS, BrownMA, MangosG, DavisGK: Non-proteinuric pre-eclampsia: A novel risk indicator in women with gestational hypertension. J Hypertens26: 295–302, 2008PubMed
BramhamK, SeedPT, LightstoneL, Nelson-PiercyC, GillC, WebsterP, et al.: Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease. Kidney Int89: 874–885, 2016PubMed
BramhamK, SeedPT, LightstoneL, Nelson-PiercyC, GillC, WebsterP, : Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease. Kidney Int 89: 874–885, 2016PubMed)| false
PerniU, SisonC, SharmaV, HelsethG, HawfieldA, SuthanthiranM, et al.: Angiogenic factors in superimposed preeclampsia: A longitudinal study of women with chronic hypertension during pregnancy. Hypertension59: 740–746, 2012PubMed
PerniU, SisonC, SharmaV, HelsethG, HawfieldA, SuthanthiranM, : Angiogenic factors in superimposed preeclampsia: A longitudinal study of women with chronic hypertension during pregnancy. Hypertension 59: 740–746, 2012PubMed)| false
National Guideline Alliance; Royal College of Obstetricians and Gynaecologists: Hypertension in pregnancy: [C] Evidence review for prediction of complications in pre-eclampsia. NICE guideline NG133, London, National Institute for Health and Care Excellence, 2019. Available at: https://www.nice.org.uk/guidance/ng133/evidence/c-prediction-of-complications-in-preeclampsia-pdf-6836186128. Accessed December 29, 2021)| false
LimS, LiW, KemperJ, NguyenA, MolB, ReddyM: Biomarkers and the prediction of adverse outcomes in preeclampsia: A systematic review and meta-analysis. Obstet Gynecol137: 72–81, 2021PubMed
LimS, LiW, KemperJ, NguyenA, MolB, ReddyM: Biomarkers and the prediction of adverse outcomes in preeclampsia: A systematic review and meta-analysis. Obstet Gynecol 137: 72–81, 2021PubMed)| false
RanaS, KarumanchiSA, LindheimerMD: Angiogenic factors in diagnosis, management, and research in preeclampsia. Hypertension 63: 198–202, 2014PubMed)| false
DrögeLA, PerschelFH, StützN, GafronA, FrankL, BusjahnA, et al.: Prediction of preeclampsia-related adverse outcomes with the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor)-ratio in the clinical routine: A real-world study. Hypertension77: 461–471, 2021PubMed
GiannakouK, EvangelouE, PapatheodorouSI: Genetic and non-genetic risk factors for pre-eclampsia: Umbrella review of systematic reviews and meta-analyses of observational studies. Ultrasound Obstet Gynecol51: 720–730, 2018PubMed
YagelS, CohenSM, Goldman-WohlD: An integrated model of preeclampsia: A multifaceted syndrome of the maternal cardiovascular-placental-fetal array. Am J Obstet Gynecol226: S963–S972, 2022PubMed
YagelS, CohenSM, Goldman-WohlD: An integrated model of preeclampsia: A multifaceted syndrome of the maternal cardiovascular-placental-fetal array. Am J Obstet Gynecol 226: S963–S972, 2022PubMed)| false
DavidsonKW, BarryMJ, MangioneCM, CabanaM, CaugheyAB, DavisEM, et al.; US Preventive Services Task Force: Aspirin use to prevent preeclampsia and related morbidity and mortality: US Preventive Services Task Force Recommendation Statement. JAMA326: 1186–1191, 2021PubMed
DavidsonKW, BarryMJ, MangioneCM, CabanaM, CaugheyAB, DavisEM, ; US Preventive Services Task Force: Aspirin use to prevent preeclampsia and related morbidity and mortality: US Preventive Services Task Force Recommendation Statement. JAMA 326: 1186–1191, 2021PubMed)| false
BartschE, MedcalfKE, ParkAL, RayJG; High Risk of Pre-eclampsia Identification Group: Clinical risk factors for pre-eclampsia determined in early pregnancy: Systematic review and meta-analysis of large cohort studies. BMJ353: i1753, 2016PubMed
BartschE, MedcalfKE, ParkAL, RayJG; High Risk of Pre-eclampsia Identification Group: Clinical risk factors for pre-eclampsia determined in early pregnancy: Systematic review and meta-analysis of large cohort studies. BMJ 353: i1753, 2016PubMed)| false
ZhangJJ, MaXX, HaoL, LiuLJ, LvJC, ZhangH: A systematic review and meta-analysis of outcomes of pregnancy in CKD and CKD outcomes in pregnancy. Clin J Am Soc Nephrol10: 1964–1978, 2015PubMed
ZhangJJ, MaXX, HaoL, LiuLJ, LvJC, ZhangH: A systematic review and meta-analysis of outcomes of pregnancy in CKD and CKD outcomes in pregnancy. Clin J Am Soc Nephrol 10: 1964–1978, 2015PubMed)| false
BerntsenS, Söderström-AnttilaV, WennerholmUB, LaivuoriH, LoftA, OldereidNB, et al.: The health of children conceived by ART: ‘The chicken or the egg?’. Hum Reprod Update25: 137–158, 2019PubMed
BerntsenS, Söderström-AnttilaV, WennerholmUB, LaivuoriH, LoftA, OldereidNB, : The health of children conceived by ART: ‘The chicken or the egg?’. Hum Reprod Update 25: 137–158, 2019PubMed)| false
PoonLC, RolnikDL, TanMY, DelgadoJL, TsokakiT, AkolekarR, et al.: ASPRE trial: Incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm. Ultrasound Obstet Gynecol51: 738–742, 2018PubMed
The Fetal Medicine Foundation: Risk for preeclampsia. Available at: https://fetalmedicine.org/research/assess/preeclampsia/first-trimester. Accessed December 29, 2020)| false
Al-RubaieZ, AskieLM, RayJG, HudsonHM, LordSJ: The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: A systematic review. BJOG123: 1441–1452, 2016PubMed
Al-RubaieZ, AskieLM, RayJG, HudsonHM, LordSJ: The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: A systematic review. BJOG 123: 1441–1452, 2016PubMed)| false
TongS, Kaitu’u-LinoTJ, HastieR, BrownfootF, CluverC, HannanN: Pravastatin, proton-pump inhibitors, metformin, micronutrients, and biologics: New horizons for the prevention or treatment of preeclampsia. Am J Obstet Gynecol226: S1157–S1170, 2022PubMed
TongS, Kaitu’u-LinoTJ, HastieR, BrownfootF, CluverC, HannanN: Pravastatin, proton-pump inhibitors, metformin, micronutrients, and biologics: New horizons for the prevention or treatment of preeclampsia. Am J Obstet Gynecol 226: S1157–S1170, 2022PubMed)| false
DobertM, WrightA, VarouxakiAN, MuAC, SyngelakiA, RehalA, et al.: STATIN trial: Predictive performance of competing-risk model in screening for pre-eclampsia at 35-37 weeks’ gestation. Ultrasound Obstet Gynecol59: 69–75, 2022PubMed
RodgerMA, GrisJC, de VriesJIP, MartinelliI, ReyÉ, SchleussnerE, et al.; Low-Molecular-Weight Heparin for Placenta-Mediated Pregnancy Complications Study Group: Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: A meta-analysis of individual patient data from randomised controlled trials. Lancet388: 2629–2641, 2016PubMed
RodgerMA, GrisJC, de VriesJIP, MartinelliI, ReyÉ, SchleussnerE, ; Low-Molecular-Weight Heparin for Placenta-Mediated Pregnancy Complications Study Group: Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: A meta-analysis of individual patient data from randomised controlled trials. Lancet 388: 2629–2641, 2016PubMed)| false
DavenportMH, RuchatSM, PoitrasVJ, Jaramillo GarciaA, GrayCE, BarrowmanN, et al.: Prenatal exercise for the prevention of gestational diabetes mellitus and hypertensive disorders of pregnancy: A systematic review and meta-analysis. Br J Sports Med52: 1367–1375, 2018PubMed
DavenportMH, RuchatSM, PoitrasVJ, Jaramillo GarciaA, GrayCE, BarrowmanN, : Prenatal exercise for the prevention of gestational diabetes mellitus and hypertensive disorders of pregnancy: A systematic review and meta-analysis. Br J Sports Med 52: 1367–1375, 2018PubMed)| false
KinshellaMW, SarrC, SandhuA, BoneJN, VidlerM, MooreSE, et al.: Calcium for pre-eclampsia prevention: A systematic review and network meta-analysis to guide personalised antenatal care [published online ahead of print May 20, 2022]. BJOG10.1111/1471-0528.17222
KinshellaMW, SarrC, SandhuA, BoneJN, VidlerM, MooreSE, : Calcium for pre-eclampsia prevention: A systematic review and network meta-analysis to guide personalised antenatal care [published online ahead of print May 20, 2022]. BJOG 10.1111/1471-0528.17222)| false
RolnikDL, WrightD, PoonLC, O’GormanN, SyngelakiA, de Paco MatallanaC, et al.: Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med377: 613–622, 2017PubMed
RolnikDL, WrightD, PoonLC, O’GormanN, SyngelakiA, de Paco MatallanaC, : Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med 377: 613–622, 2017PubMed)| false
OrtvedD, HawkinsTL, JohnsonJA, HyettJ, MetcalfeA: Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset pre-eclampsia. Ultrasound Obstet Gynecol53: 239–244, 2019PubMed
OrtvedD, HawkinsTL, JohnsonJA, HyettJ, MetcalfeA: Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset pre-eclampsia. Ultrasound Obstet Gynecol 53: 239–244, 2019PubMed)| false
RobergeS, BujoldE, NicolaidesKH: Aspirin for the prevention of preterm and term preeclampsia: Systematic review and metaanalysis. Am J Obstet Gynecol218: 287–293.e1, 2018PubMed
RobergeS, BujoldE, NicolaidesKH: Aspirin for the prevention of preterm and term preeclampsia: Systematic review and metaanalysis. Am J Obstet Gynecol 218: 287–293.e1, 2018PubMed)| false
AskieLM, DuleyL, Henderson-SmartDJ, StewartLA; PARIS Collaborative Group: Antiplatelet agents for prevention of pre-eclampsia: A meta-analysis of individual patient data. Lancet369: 1791–1798, 2007PubMed
AskieLM, DuleyL, Henderson-SmartDJ, StewartLA; PARIS Collaborative Group: Antiplatelet agents for prevention of pre-eclampsia: A meta-analysis of individual patient data. Lancet 369: 1791–1798, 2007PubMed)| false
WernerEF, HauspurgAK, RouseDJ: A cost-benefit analysis of low-dose aspirin prophylaxis for the prevention of preeclampsia in the United States. Obstet Gynecol126: 1242–1250, 2015PubMed
WernerEF, HauspurgAK, RouseDJ: A cost-benefit analysis of low-dose aspirin prophylaxis for the prevention of preeclampsia in the United States. Obstet Gynecol 126: 1242–1250, 2015PubMed)| false
HastieR, TongS, WikstromAK, SandstromA, HesselmanS, BergmanL: Aspirin use during pregnancy and the risk of bleeding complications: A Swedish population-based cohort study. Am J Obstet Gynecol224: 95.e1–95.e12, 2021PubMed
HastieR, TongS, WikstromAK, SandstromA, HesselmanS, BergmanL: Aspirin use during pregnancy and the risk of bleeding complications: A Swedish population-based cohort study. Am J Obstet Gynecol 224: 95.e1–95.e12, 2021PubMed)| false
CMQCC: Improving Health Care Response to Preeclampsia: A California Toolkit to Transform Maternity Care (California Maternal Quality Care Collaborative), 2014. Available at: https://wwwcmqccorg/resources-tool-kits/toolkits/preeclampsia-toolkit. Accessed December 29, 2021)| false
MageeLA, von DadelszenP, SingerJ, LeeT, ReyE, RossS, et al.; CHIPS Study Group: The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study): Is severe hypertension just an elevated blood pressure?Hypertension68: 1153–1159, 2016PubMed
MageeLA, von DadelszenP, SingerJ, LeeT, ReyE, RossS, ; CHIPS Study Group: The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study): Is severe hypertension just an elevated blood pressure? Hypertension 68: 1153–1159, 2016PubMed)| false
SridharanK, SequeiraRP: Drugs for treating severe hypertension in pregnancy: A network meta-analysis and trial sequential analysis of randomized clinical trials. Br J Clin Pharmacol84: 1906–1916, 2018PubMed
SridharanK, SequeiraRP: Drugs for treating severe hypertension in pregnancy: A network meta-analysis and trial sequential analysis of randomized clinical trials. Br J Clin Pharmacol 84: 1906–1916, 2018PubMed)| false
AlavifardS, ChaseR, JanoudiG, ChaumontA, LanesA, WalkerM, et al.: First-line antihypertensive treatment for severe hypertension in pregnancy: A systematic review and network meta-analysis. Pregnancy Hypertens18: 179–187, 2019PubMed
EasterlingT, MundleS, BrackenH, ParvekarS, MoolS, MageeLA, et al.: Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: An open-label, randomised controlled trial. Lancet394: 1011–1021, 2019PubMed
MageeLA, von DadelszenP, ReyE, RossS, AsztalosE, MurphyKE, et al.: Less-tight versus tight control of hypertension in pregnancy. N Engl J Med372: 407–417, 2015PubMed
MageeLA, von DadelszenP, ReyE, RossS, AsztalosE, MurphyKE, : Less-tight versus tight control of hypertension in pregnancy. N Engl J Med 372: 407–417, 2015PubMed)| false
AbalosE, DuleyL, SteynDW, GialdiniC: Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev10: CD002252, 2018PubMed
MageeLA, KhalilA, von DadelszenP: Pregnancy hypertension diagnosis and care in COVID-19 era and beyond. Ultrasound Obstet Gynecol 56: 7–10, 2020PubMed)| false
ButaliaS, AudibertF, CôtéAM, FirozT, LoganAG, MageeLA, et al.; Hypertension Canada: Hypertension Canada’s 2018 Guidelines for the Management of Hypertension in Pregnancy. Can J Cardiol34: 526–531, 2018PubMed
British Association of Perinatal Medicine: Identification and Management of Neonatal Hypoglycaemia in the Full Term Infant (2017): A BAPM Framework for Practice, 2017. Available at: https://www.bapm.org/resources/40-identification-and-management-of-neonatal-hypoglycaemia-in-the-full-term-infant-2017. Accessed December 29, 2021)| false
FittonCA, SteinerMFC, AucottL, PellJP, MackayDF, FlemingM, et al.: In-utero exposure to antihypertensive medication and neonatal and child health outcomes: A systematic review. J Hypertens35: 2123–2137, 2017PubMed
BatemanBT, HuybrechtsKF, FischerMA, SeelyEW, EckerJL, ObergAS, et al.: Chronic hypertension in pregnancy and the risk of congenital malformations: A cohort study. Am J Obstet Gynecol212: 337.e1–337.e14, 2015PubMed
BatemanBT, HuybrechtsKF, FischerMA, SeelyEW, EckerJL, ObergAS, : Chronic hypertension in pregnancy and the risk of congenital malformations: A cohort study. Am J Obstet Gynecol 212: 337.e1–337.e14, 2015PubMed)| false
Weber-SchoendorferC, KayserA, Tissen-DiabatéT, WinterfeldU, EleftheriouG, Te WinkelB, et al.: Fetotoxic risk of AT1 blockers exceeds that of angiotensin-converting enzyme inhibitors: An observational study. J Hypertens38: 133–141, 2020PubMed
FisherSC, Van ZutphenAR, WerlerMM, LinAE, RomittiPA, DruschelCM, et al.; National Birth Defects Prevention Study: Maternal antihypertensive medication use and congenital heart defects: Updated results from the National Birth Defects Prevention Study. Hypertension69: 798–805, 2017PubMed
FisherSC, Van ZutphenAR, WerlerMM, LinAE, RomittiPA, DruschelCM, ; National Birth Defects Prevention Study: Maternal antihypertensive medication use and congenital heart defects: Updated results from the National Birth Defects Prevention Study. Hypertension 69: 798–805, 2017PubMed)| false
ThorntonCE, von DadelszenP, MakrisA, TooherJM, OgleRF, HennessyA: Acute pulmonary oedema as a complication of hypertension during pregnancy. Hypertens Pregnancy30: 169–179, 2011PubMed
ThorntonCE, von DadelszenP, MakrisA, TooherJM, OgleRF, HennessyA: Acute pulmonary oedema as a complication of hypertension during pregnancy. Hypertens Pregnancy 30: 169–179, 2011PubMed)| false
NasabSH, MoussaHN, AlraisMA, SibaiBM, BahaM, BlackwellSC: Postpartum readmissions: What we can learn from numbers?Obstet Gynecol131: 123S, 201810.097/01.AOG.0000533520.08596.85
NasabSH, MoussaHN, AlraisMA, SibaiBM, BahaM, BlackwellSC: Postpartum readmissions: What we can learn from numbers? Obstet Gynecol 131: 123S, 201810.097/01.AOG.0000533520.08596.85)| false
MalhaméI, DanilackVA, RakerCA, HardyEJ, SpaldingH, BouvierBA, et al.: Cardiovascular severe maternal morbidity in pregnant and postpartum women: Development and internal validation of risk prediction models. BJOG128: 922–932, 2021PubMed
MalhaméI, DanilackVA, RakerCA, HardyEJ, SpaldingH, BouvierBA, : Cardiovascular severe maternal morbidity in pregnant and postpartum women: Development and internal validation of risk prediction models. BJOG 128: 922–932, 2021PubMed)| false
BlueNR, Murray-KrezanC, Drake-LavelleS, WeinbergD, HolbrookBD, KatukuriVR, et al.: Effect of ibuprofen vs acetaminophen on postpartum hypertension in preeclampsia with severe features: A double-masked, randomized controlled trial. Am J Obstet Gynecol218: 616.e1–616.e8, 2018
BlueNR, Murray-KrezanC, Drake-LavelleS, WeinbergD, HolbrookBD, KatukuriVR, : Effect of ibuprofen vs acetaminophen on postpartum hypertension in preeclampsia with severe features: A double-masked, randomized controlled trial. Am J Obstet Gynecol 218: 616.e1–616.e8, 2018)| false
Vigil-De GraciaP, SolisV, OrtegaN: Ibuprofen versus acetaminophen as a post-partum analgesic for women with severe preeclampsia: Randomized clinical study. J Matern Fetal Neonatal Med30: 1279–1282, 2017PubMed
Vigil-De GraciaP, SolisV, OrtegaN: Ibuprofen versus acetaminophen as a post-partum analgesic for women with severe preeclampsia: Randomized clinical study. J Matern Fetal Neonatal Med 30: 1279–1282, 2017PubMed)| false
National Library of Medicine: Drugs and Lactation Database (LactMed), 2006. Available at: https://www.ncbi.nlm.nih.gov/books/NBK501922/?term=lactmed. Accessed December 29, 2021)| false
van OostwaardMF, LangenveldJ, SchuitE, PapatsonisDN, BrownMA, ByaruhangaRN, et al.: Recurrence of hypertensive disorders of pregnancy: An individual patient data metaanalysis. Am J Obstet Gynecol212: 624.e1–624.e17, 2015PubMed
van OostwaardMF, LangenveldJ, SchuitE, PapatsonisDN, BrownMA, ByaruhangaRN, : Recurrence of hypertensive disorders of pregnancy: An individual patient data metaanalysis. Am J Obstet Gynecol 212: 624.e1–624.e17, 2015PubMed)| false
KhoslaK, HeimbergerS, NiemanKM, TungA, ShahulS, StaffAC, et al.: Long-term cardiovascular disease risk in women after hypertensive disorders of pregnancy: Recent advances in hypertension. Hypertension78: 927–935, 2021PubMed
MarkovitzAR, StuartJJ, HornJ, WilliamsPL, RimmEB, MissmerSA, et al.: Does pregnancy complication history improve cardiovascular disease risk prediction? Findings from the HUNT study in Norway. Eur Heart J40: 1113–1120, 2019PubMed
MarkovitzAR, StuartJJ, HornJ, WilliamsPL, RimmEB, MissmerSA, : Does pregnancy complication history improve cardiovascular disease risk prediction? Findings from the HUNT study in Norway. Eur Heart J 40: 1113–1120, 2019PubMed)| false
UkahUV, DayanN, AugerN, HeS, PlattRW: Development and internal validation of a model predicting premature cardiovascular disease among women with hypertensive disorders of pregnancy: A population-based study in Quebec, Canada. J Am Heart Assoc9: e017328, 2020PubMed
UkahUV, DayanN, AugerN, HeS, PlattRW: Development and internal validation of a model predicting premature cardiovascular disease among women with hypertensive disorders of pregnancy: A population-based study in Quebec, Canada. J Am Heart Assoc 9: e017328, 2020PubMed)| false
MageeLA, BrownMA, HallDR, GupteS, HennessyA, KarumanchiSA, et al.: The hypertensive disorders of pregnancy: The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis and management recommendations for international practice. Pregnancy Hypertens27: 148–169, 2022
MageeLA, BrownMA, HallDR, GupteS, HennessyA, KarumanchiSA, : The hypertensive disorders of pregnancy: The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis and management recommendations for international practice. Pregnancy Hypertens 27: 148–169, 2022)| false